![](https://pmlive.com/wp-content/uploads/2024/02/Clinical_development-1.jpg)
Study reveals GLP-1s could reduce risk of cancer in patients with type 2 diabetes
A new study conducted by researchers at Case Western Reserve University School of Medicine, Ohio, has revealed that patients living with type 2 diabetes (T2D) treated with semaglutide are less likely to develop certain cancers. The research published in …